4 1 har121802.htm FORM 4 - DECEMBER 18, 2002 SEC Form 4
FORM 4

[ ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

(Print or Type Responses)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL



OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5
1. Name and Address of Reporting Person*
Hardwick, Charles     L.

(Last)                      (First)                      (Middle)
Pfizer Inc. Att: Corporate Secretary
235 East 42nd Street

(Street)
New York, NY     10017

(City)                      (State)                      (Zip)

2. Issuer Name and Ticker or Trading Symbol

Pfizer Inc   (PFE)
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

                        Director                           10% Owner
           X          Officer                             Other
          Senior Vice President

7. Individual or Joint/Group Filing (Check Applicable Line)

X   Form filed by One Reporting Person
      Form filed by More than One Reporting Person
3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)
4. Statement for
    Month/Day/Year

    December 18, 2002


5. If Amendment,
    Date of Original
    (Month/Day/Year)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)
2A. Deemed
      Execution
      Date, if any

      (Month/Day/Year)
3. Transaction
    Code
    and
    Voluntary
    Code
    (Instr. 8)



Code  |  V    
4. Securities Acquired (A) or Disposed (D) Of
    (Instr. 3, 4, and 5)





        Amount      |         A/D         |         Price          
5. Amount of
    Securities
    Beneficially
    Owned
    Following
    Reported
Transaction(s)

    (Instr. 3 and 4)
6. Owner-
    ship
    Form:
    Direct(D)
    or
    Indirect (I)

    (Instr. 4)
7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)
Common Stock
08/06/2002

   L |     
        32   |           A           |   $30.96

D

Common Stock
09/27/2002

   L |     
  27(1)   |           A           |   $29.79

D

Common Stock
10/14/2002

   L |     
        32   |           A           |   $30.86

D

Common Stock
12/18/2002

   S |     
  30(1)   |           D           |   $30.10
7,725
D

Common Stock




39,543
I
By Rule 16b-3 Plan








Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

Persons who respond to the collection of information contained in this form are not required to
respond unless the form displays a currently valid OMB control number.
(over)
SEC 1474 (9-02)

Hardwick, Charles L. - December 18, 2002
Form 4 (continued)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
    (Instr. 3)
2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security
3. Transaction
    Date

    (Month/
    Day/
    Year)
3A. Deemed
      Execution
      Date, if
      any

      (Month/
      Day/
      Year)
4. Transaction
    Code
    and
    Voluntary (V)
    Code
    (Instr.8)



Code | V    
5. Number of Derivative
    Securities Acquired (A)
    or Disposed (D) Of

    (Instr. 3,4 and 5)
6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)






  (DE)     |     (ED)  
7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)
8. Price
    of
    Derivative
    Security
    (Instr.5)
9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    Following
    Reported
    Transactions
    (Instr.4)
10.
Owner-
ship
Form of
Deriv-
ative
Security:
Direct
(D)
or
Indirect
(I)
(Instr.4)
11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)












Explanation of Responses :


** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB number.


By: Margaret M. Foran for

      Charles L. Hardwick             
       
           02-14-2003    
** Signature of Reporting Person                         Date


Power of Attorney

Page 2

Hardwick, Charles L. - December 18, 2002
Form 4 (continued)
FOOTNOTE Descriptions for Pfizer Inc (PFE)

Form 4 - December 18, 2002

Charles L. Hardwick
Pfizer Inc. Att: Corporate Secretary
235 East 42nd Street
New York, NY 10017

Explanation of responses:

(1)   Mr. Hardwick paid Pfizer Inc. $8.13 representing disgorgement of short-swing profit resulting from the purchase of 27 shares of Pfizer Inc. on September 27, 2002 at $29.79 per share (total purchase price of $804.57) and the sale of 27 shares of Pfizer Inc. on December 18, 2002 at $30.10 per share (total sale proceeds of $812.70). These purchases and sale transactions were effected by Mr. Hardwick's portfolio manager without his prior knowledge.
Page 3